Waypoint Bio co-founders and Xinchen Wang (L) and David Phizicky (Credit: Waypoint Bio)
Exclusive: To develop better cell therapies for solid tumors, a new startup plans to test hundreds of them at once
Therapies made from a patient’s own immune cells have spurred medical miracles for many people with advanced blood cancers, but getting those CAR-T cell therapies …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.